Literature DB >> 7139394

Comparison of the caffeine skinned fibre tension (CSFT) test with the caffeine-halothane contracture (CHC) test in the diagnosis of malignant hyperthermia.

B A Britt, W Frodis, E Scott, M J Clements, L Endrenyi.   

Abstract

We have compared and contrasted two diagnostic tests for Malignant Hyperthermia (MH) - the Caffeine-Halothane Contracture Test and the Caffeine Skinned Fibre Tension Test. Both tests show a strongly positive relationship both with the occurrence of MH reactions and with each other. The former test is more rapid and requires less skill. The latter test can be performed on much less muscle and permits storage of the muscle over prolonged periods of time.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7139394     DOI: 10.1007/bf03007740

Source DB:  PubMed          Journal:  Can Anaesth Soc J        ISSN: 0008-2856


  22 in total

1.  Malignant hyperthermia--an investigation of three patients.

Authors:  B A Britt
Journal:  Ann R Coll Surg Engl       Date:  1971-02       Impact factor: 1.891

2.  Some properties of fragmented frog sarcoplasmic reticulum with particular reference to its response to caffeine.

Authors:  Y Ogawa
Journal:  J Biochem       Date:  1970-05       Impact factor: 3.387

3.  Halothane-induced muscle contracture as a cause of hyperpyrexia.

Authors:  F R Ellis; D G Harriman; N P Keaney; K Kyei-Mensah; J H Tyrrell
Journal:  Br J Anaesth       Date:  1971-07       Impact factor: 9.166

4.  Metabolic error of muscle metabolism after recovery from malignant hyperthermia.

Authors:  W Kalow; B A Britt; M E Terreau; C Haist
Journal:  Lancet       Date:  1970-10-31       Impact factor: 79.321

5.  Comparison of effects of several inhalation anaesthetics on caffeine-induced contractures of normal and malignant hyperthermic skeletal muscle.

Authors:  B A Britt; L Endrenyi; W Frodis; E Scott; W Kalow
Journal:  Can Anaesth Soc J       Date:  1980-01

6.  Effect of temperature, time and fascicle size on the caffeine contracture test.

Authors:  B A Britt; L Endrenyi; E Scott; W Frodis
Journal:  Can Anaesth Soc J       Date:  1980-01

7.  Human skeletal muscle: analysis of Ca2+ regulation in skinned fibers using caffeine.

Authors:  D S Wood
Journal:  Exp Neurol       Date:  1978-01-15       Impact factor: 5.330

8.  Porcine malignant hyperthermia: effects of temperature and extracellular calcium concentration on halothane-induced contracture of susceptible skeletal muscle.

Authors:  T E Nelson; D M Bedell; E W Jones
Journal:  Anesthesiology       Date:  1975-03       Impact factor: 7.892

9.  The adenosine triphosphate (ATP) depletion test: comparison with the caffeine contracture test as a method of diagnosing malignant hyperthermia susceptibility.

Authors:  B A Britt; L Endrenyi; W Kalow; P L Peters
Journal:  Can Anaesth Soc J       Date:  1976-11

10.  INHIBITION OF CAFFEINE RIGOR AND RADIOCALCIUM MOVEMENTS BY LOCAL ANESTHETICS IN FROG SARTORIUS MUSCLE.

Authors:  M B FEINSTEIN
Journal:  J Gen Physiol       Date:  1963-09       Impact factor: 4.086

View more
  5 in total

1.  Malignant hyperthermia.

Authors:  B A Britt
Journal:  Can Anaesth Soc J       Date:  1985-11

2.  Dantrolene--in vitro studies in malignant hyperthermia susceptible (MHS) and normal skeletal muscle.

Authors:  B A Britt; E Scott; W Frodis; M J Clements; L Endrenyi
Journal:  Can Anaesth Soc J       Date:  1984-03

3.  Porcine malignant hyperthermia susceptibility: hypersensitive calcium-release mechanism of skeletal muscle sarcoplasmic reticulum.

Authors:  P J O'Brien
Journal:  Can J Vet Res       Date:  1986-07       Impact factor: 1.310

4.  Erythrocyte osmotic fragility testing and the prediction of canine malignant hyperthermia susceptibility.

Authors:  P H Cribb; E A Olfert; F B Reynolds
Journal:  Can Vet J       Date:  1986-12       Impact factor: 1.008

5.  Canine malignant hyperthermia: diagnosis of susceptibility in a breeding colony.

Authors:  P J O'brien; P H Cribb; R J White; E D Olfert; J E Steiss
Journal:  Can Vet J       Date:  1983-06       Impact factor: 1.008

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.